FBXO4 loss facilitates carcinogen induced papilloma development in mice

References

• Diehl JA. Cycling to Cancer with Cyclin Dl. Cancer Biol Ther 2002; 1:226-231; PMID:12432268; http://dx.doi.org/10.4161/cbt.72
   PubMed Web of Science ®Google Scholar
• Lin DI, Barbash O, Kumar KG, Weber JD, Harper JW, Klein-Szanto AJ, Rustgi A, Fuchs SY, Diehl JA. Phosphorylation-dependent ubiquitination of cyclin D1 by the SCF(FBX4-alphaB crystallin) complex. Mol Cell 2006; 24:355-366; PMID:17081987; http://dx.doi.org/10.1016/j.molcel.2006.09.007
   PubMed Web of Science ®Google Scholar
• Barbash O, Zamfirova P, Lin DI, Chen X, Yang K, Nakagawa H, Lu F, Rustgi AK, Diehl JA. Mutations in Fbx4 inhibit dimerization of the SCF(Fbx4) ligase and contribute to cyclin D1 overexpression in human cancer. Cancer Cell 2008; 14:68-78; PMID:18598945; http://dx.doi.org/10.1016/j.ccr.2008.05.017
   PubMed Web of Science ®Google Scholar
• Lee EK, Lian Z, D'Andrea K, Letrero R, Sheng W, Liu S, Diehl JN, Pytel D, Barbash O, Schuchter L, et al. The FBXO4 tumor suppressor functions as a barrier to BRAFV600E-dependent metastatic melanoma. Mol Cell Biol 2013; 33:4422-4433; PMID:24019069; http://dx.doi.org/10.1128/MCB.00706-13
   PubMed Web of Science ®Google Scholar
• Vaites LP, Lee EK, Lian Z, Barbash O, Roy D, Wasik M, Klein-Szanto AJ, Rustgi AK, Diehl JA. The Fbx4 tumor suppressor regulates cyclin D1 accumulation and prevents neoplastic transformation. Mol Cell Biol 2011; 31:4513-4523; PMID:21911473; http://dx.doi.org/10.1128/MCB.05733-11
   PubMed Web of Science ®Google Scholar
• Vaites LP, Lian Z, Lee EK, Yin B, DeMicco A, Bassing CH, Diehl JA. ATM deficiency augments constitutively nuclear cyclin D1-driven genomic instability and lymphomagenesis. Oncogene 2014; 33:129-133; PMID:23318439; http://dx.doi.org/10.1038/onc.2012.577
   PubMed Web of Science ®Google Scholar
• Autrup H, Stoner GD. Metabolism of N-nitrosamines by cultured human and rat esophagus. Cancer Res 1982; 42:1307-1311; PMID:7060009
   PubMed Web of Science ®Google Scholar
• Jenkins TD, Mueller A, Odze R, Shahsafaei A, Zukerberg LR, Kent R, Stoner GD, Rustgi AK. Cyclin D1 overexpression combined with N-nitrosomethylbenzylamine increases dysplasia and cellular proliferation in murine esophageal squamous epithelium. Oncogene 1999; 18:59-66; PMID:9926920; http://dx.doi.org/10.1038/sj.onc.1202296
   PubMed Web of Science ®Google Scholar
• Stoner GD, Gupta A. Etiology and chemoprevention of esophageal squamous cell carcinoma. Carcinogenesis 2001; 22:1737-1746; PMID:11698334; http://dx.doi.org/10.1093/carcin/22.11.1737
   PubMed Web of Science ®Google Scholar
• Doniger J, Day RS, DiPaolo JA. Quantitative assessment of the role of O6-methylguanine in the initiation of carcinogenesis by methylating agents. Proc Natl Acad Sci U S A 1985; 82:421-425; PMID:3855560; http://dx.doi.org/10.1073/pnas.82.2.421
   PubMed Web of Science ®Google Scholar
• Fong LY, Lin HJ, Lee CL. Methylation of DNA in target and non-target organs of the rat with methylbenzylnitrosamine and dimethylnitrosamine. IntJ Cancer 1979; 23:679-682; PMID:457309; http://dx.doi.org/10.1002/ijc.2910230514
   PubMed Web of Science ®Google Scholar
• Harris CC, Autrup H, Stoner GD, Trump BF, Hillman E, Schafer PW, Jeffrey AM. Metabolism of benzo(a)pyrene, N-nitrosodimethylamine, and N-nitrosopyrrolidine and identification of the major carcinogen-DNA adducts formed in cultured human esophagus. Cancer research 1979; 39:4401-4406; PMID:498072
   PubMed Web of Science ®Google Scholar
• Siglin JC, Morse MA, Schut HA, Geil RG, Conran PB, Stoner GD. O6-methylguanine levels and histopathological changes in the rat esophagus and liver following single and repeated administration of N-nitrosomethylbenzylamine. Carcinogenesis 1996; 17:1135-1140; PMID:8640924; http://dx.doi.org/10.1093/carcin/17.5.1135
   PubMed Web of Science ®Google Scholar
• Van Benthem J, Vermeulen E, Winterwerp HH, Wild CP, Scherer E, Den Engelse L. Accumulation of O6- and 7-methylguanine in DNA of N-nitroso-N-methylbenzylamine-treated rats is restricted to non-target organs for N-nitroso-N-methylbenzylamine-induced carcinogenesis. Carcinogenesis 1992; 13:2101-2105; PMID:1423882; http://dx.doi.org/10.1093/carcin/13.11.2101
   PubMed Web of Science ®Google Scholar
• Tatematsu K, Koide A, Morimura K, Fukushima S, Mori Y. The enhancing effect of ethanol on the mutagenic activation of N-nitrosomethylbenzylamine by cytochrome P450 2A in the rat oesophagus. Mutagenesis 2013; 28:161-169; PMID:23325793; http://dx.doi.org/10.1093/mutage/ges066
   PubMed Web of Science ®Google Scholar
• Wang LS, Dombkowski AA, Seguin C, Rocha C, Cukovic D, Mukundan A, Henry C, Stoner GD. Mechanistic basis for the chemopreventive effects of black raspberries at a late stage of rat esophageal carcinogenesis. Mol Carcinog 2011; 50:291-300; PMID:21465577; http://dx.doi.org/10.1002/mc.20634
   PubMed Web of Science ®Google Scholar
• Fry DW, Harvey PJ, Keller PR, Elliott WL, Meade M, Trachet E, Albassam M, Zheng X, Leopold WR, Pryer NK, et al. Specific inhibition of cyclin-dependent kinase 4/6 by PD 0332991 and associated antitumor activity in human tumor xenografts. Mol Cancer Ther 2004; 3:1427-1438; PMID:15542782
   PubMed Web of Science ®Google Scholar
• Okano J, Snyder L, Rustgi AK. Genetic alterations in esophageal cancer. Methods Mol Biol 2003; 222:131-145; PMID:12710684
   PubMedGoogle Scholar
• Enzinger PC, Mayer RJ. Esophageal cancer. N Engl J Med 2003; 349:2241-2252; PMID:14657432; http://dx.doi.org/10.1056/NEJMra035010
   PubMed Web of Science ®Google Scholar
• http://www.cancer.gov/cancertopics/types/esophageal.
   Google Scholar
• Peiffer DS, Zimmerman NP, Wang LS, Ransom BW, Carmella SG, Kuo CT, Siddiqui J, Chen JH, Oshima K, Huang YW, et al. Chemoprevention of Esophageal Cancer with Black Raspberries, Their Component Anthocyanins, and a Major Anthocyanin Metabolite, Protocatechuic Acid. Cancer Prev Res 2014; 7:574-84; PMID:24667581; http://dx.doi.org/10.1158/1940-6207.CAPR-14-0003
   PubMed Web of Science ®Google Scholar
• Wang Y, You M, Reynolds SH, Stoner GD, Anderson MW. Mutational activation of the cellular Harvey ras oncogene in rat esophageal papillomas induced by methylbenzylnitrosamine. Cancer Res 1990; 50:1591-1595; PMID:2406014
   PubMed Web of Science ®Google Scholar
• Wang D, Weghorst CM, Calvert RJ, Stoner GD. Mutation in the p53 tumor suppressor gene in rat esophageal papillomas induced by N-nitrosomethylbenzylamine. Carcinogenesis 1996; 17:625-630; PMID:8625469; http://dx.doi.org/10.1093/carcin/17.4.625
   PubMed Web of Science ®Google Scholar
• Xie Y, Tang E, Ren B, Feng L. Overexpression of S-adenosylhomocysteine hydrolase and down-regulation of prohibitin and c-Myc binding protein in the human esophageal squamous cell line HEEC exposed to N-nitrosomethylbenzylamine. Mol Med Rep 2010; 3:503-508; PMID:21472270
   PubMed Web of Science ®Google Scholar
• Wang QS, Sabourin CL, Bijur GN, Robertson FM, Stoner GD. Alterations in transforming growth factor-alpha and epidermal growth factor receptor expression during rat esophageal tumorigenesis. Mol Carcinog 1996; 15:144-153; PMID:8599581; http://dx.doi.org/10.1002/(SICI)1098-2744(199602)15:2%3c144::AID-MC7%3e3.0.CO;2-J
   PubMed Web of Science ®Google Scholar
• Wang QS, Sabourin CL, Wang H, Stoner GD. Overexpression of cyclin D1 and cyclin E in N-nitrosomethylbenzylamine-induced rat esophageal tumorigenesis. Carcinogenesis 1996; 17:1583-1588; PMID:8761413; http://dx.doi.org/10.1093/carcin/17.8.1583
   PubMed Web of Science ®Google Scholar
• Youssef EM, Hasuma T, Morishima Y, Takada N, Osugi H, Higashino M, Otani S, Fukushima S. Overexpression of cyclin D1 in rat esophageal carcinogenesis model. JapJ Cancer Res 1997; 88:18-25; PMID:9045891; http://dx.doi.org/10.1111/j.1349-7006.1997.tb00296.x
   PubMed Web of Science ®Google Scholar
• Zanesi N, Fidanza V, Fong LY, Mancini R, Druck T, Valtieri M, Rüdiger T, McCue PA, Croce CM, Huebner K. The tumor spectrum in FHIT-deficient mice. Proc Natl Acad Sci U S A 2001; 98:10250-10255; PMID:11517343; http://dx.doi.org/10.1073/pnas.191345898
   PubMed Web of Science ®Google Scholar